Literature DB >> 21133692

MALDI-TOF-mass spectrometry applications in clinical microbiology.

Piseth Seng1, Jean-Marc Rolain, Pierre Edouard Fournier, Bernard La Scola, Michel Drancourt, Didier Raoult.   

Abstract

MALDI-TOF-mass spectrometry (MS) has been successfully adapted for the routine identification of microorganisms in clinical microbiology laboratories in the past 10 years. This revolutionary technique allows for easier and faster diagnosis of human pathogens than conventional phenotypic and molecular identification methods, with unquestionable reliability and cost-effectiveness. This article will review the application of MALDI-TOF-MS tools in routine clinical diagnosis, including the identification of bacteria at the species, subspecies, strain and lineage levels, and the identification of bacterial toxins and antibiotic-resistance type. We will also discuss the application of MALDI-TOF-MS tools in the identification of Archaea, eukaryotes and viruses. Pathogenic identification from colony-cultured, blood-cultured, urine and environmental samples is also reviewed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21133692     DOI: 10.2217/fmb.10.127

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  110 in total

1.  Implementation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry in Routine Clinical Laboratories Improves Identification of Coagulase-Negative Staphylococci and Reveals the Pathogenic Role of Staphylococcus lugdunensis.

Authors:  Xavier Argemi; Philippe Riegel; Thierry Lavigne; Nicolas Lefebvre; Nicolas Grandpré; Yves Hansmann; Benoit Jaulhac; Gilles Prévost; Frédéric Schramm
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

2.  MALDI biotyper-based rapid resistance detection by stable-isotope labeling.

Authors:  Katrin Sparbier; Christoph Lange; Jette Jung; Andreas Wieser; Sören Schubert; Markus Kostrzewa
Journal:  J Clin Microbiol       Date:  2013-09-04       Impact factor: 5.948

Review 3.  Update on tick-borne rickettsioses around the world: a geographic approach.

Authors:  Philippe Parola; Christopher D Paddock; Cristina Socolovschi; Marcelo B Labruna; Oleg Mediannikov; Tahar Kernif; Mohammad Yazid Abdad; John Stenos; Idir Bitam; Pierre-Edouard Fournier; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

4.  A commentary on the role of molecular technology and automation in clinical diagnostics.

Authors:  Ciara O'Connor; Marie Fitzgibbon; James Powell; Denis Barron; Jim O'Mahony; Lorraine Power; Nuala H O'Connell; Colum Dunne
Journal:  Bioengineered       Date:  2014-03-21       Impact factor: 3.269

5.  Identification of CMY-2-type cephalosporinases in clinical isolates of Enterobacteriaceae by MALDI-TOF MS.

Authors:  C C Papagiannitsis; S D Kotsakis; Z Tuma; M Gniadkowski; V Miriagou; J Hrabak
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

6.  Evaluation of the MALDI-TOF MS profiling for identification of newly described Aeromonas spp.

Authors:  Andrea Vávrová; Tereza Balážová; Ivo Sedláček; Ludmila Tvrzová; Ondrej Šedo
Journal:  Folia Microbiol (Praha)       Date:  2014-12-19       Impact factor: 2.099

7.  The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota.

Authors:  Jean-Christophe Lagier; Perrine Hugon; Saber Khelaifia; Pierre-Edouard Fournier; Bernard La Scola; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

8.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid identification of tick vectors.

Authors:  Amina Yssouf; Christophe Flaudrops; Rezak Drali; Tahar Kernif; Cristina Socolovschi; Jean-Michel Berenger; Didier Raoult; Philippe Parola
Journal:  J Clin Microbiol       Date:  2012-12-05       Impact factor: 5.948

9.  Description of Gabonibacter massiliensis gen. nov., sp. nov., a New Member of the Family Porphyromonadaceae Isolated from the Human Gut Microbiota.

Authors:  Gaël Mourembou; Jaishriram Rathored; Jean Bernard Lekana-Douki; Angélique Ndjoyi-Mbiguino; Saber Khelaifia; Catherine Robert; Nicholas Armstrong; Didier Raoult; Pierre-Edouard Fournier
Journal:  Curr Microbiol       Date:  2016-09-15       Impact factor: 2.188

Review 10.  Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine.

Authors:  Inci Yildirim; Kimberly M Shea; Stephen I Pelton
Journal:  Infect Dis Clin North Am       Date:  2015-12       Impact factor: 5.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.